{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:43:21Z","timestamp":1761101001173},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T00:00:00Z","timestamp":1231718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T00:00:00Z","timestamp":1231718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1038\/bmt.2008.401","type":"journal-article","created":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T16:49:39Z","timestamp":1231778979000},"page":"845-851","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Outcomes after auto-SCT in African Americans with multiple myeloma"],"prefix":"10.1038","volume":"43","author":[{"given":"Y","family":"Khaled","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M H","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Janakiraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J E","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Peres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Hanbali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Mineishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,12]]},"reference":[{"key":"BFbmt2008401_CR1","unstructured":"SEER database. http:\/\/seer.cancer.gov."},{"key":"BFbmt2008401_CR2","first-page":"79","volume":"50","author":"HD Vlajinac","year":"2003","unstructured":"Vlajinac HD, Pekmezovi\u0107 TD, Adanja BBJ, Marinkovi\u0107 JM, Kanazir MS, Suvajdzi\u0107 ND et al. Case-control study of multiple myeloma with special reference to diet as risk factor. Neoplasma 2003; 50: 79\u201383.","journal-title":"Neoplasma"},{"key":"BFbmt2008401_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/1047-2797(93)90071-B","volume":"3","author":"GD Friedman","year":"1993","unstructured":"Friedman GD . Cigarette smoking, leukemia, and multiple myeloma. Ann Epidemiol 1993; 3: 425\u2013428.","journal-title":"Ann Epidemiol"},{"key":"BFbmt2008401_CR4","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2003; 348: 1625\u20131638.","journal-title":"N Engl J Med"},{"key":"BFbmt2008401_CR5","first-page":"1410","volume":"91","author":"RM Abou-Jawde","year":"2006","unstructured":"Abou-Jawde RM, Baz R, Walker E, Choueiri TK, Karam MA, Reed J et al. The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma. Haematologica 2006; 91: 1410\u20131413.","journal-title":"Haematologica"},{"key":"BFbmt2008401_CR6","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1182\/blood-2005-08-3449","volume":"107","author":"O Landgren","year":"2006","unstructured":"Landgren O, Gridley G, Turesson I, Caporaso NE, Goldin LR, Baris D et al. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood 2006; 107: 904\u2013906.","journal-title":"Blood"},{"key":"BFbmt2008401_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Fran\u00e7ais du My\u00e9lome. N Engl J Med 1996; 335: 91\u201397.","journal-title":"N Engl J Med"},{"key":"BFbmt2008401_CR8","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875\u20131883.","journal-title":"N Engl J Med"},{"key":"BFbmt2008401_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/sj.bmt.1705392","volume":"37","author":"S Saraf","year":"2006","unstructured":"Saraf S, Chen YH, Dobogai LC, Mahmud N, Peace D, Saunthararajah Y et al. Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myeloma. Bone Marrow Transplant 2006; 37: 1099\u20131102.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008401_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/ajh.21139","volume":"83","author":"PS Verma","year":"2008","unstructured":"Verma PS, Howard RS, Weiss BM . The impact of race on outcomes of autologous transplantation in patients with multiple myeloma. Am J Hematol 2008; 83: 355\u2013358.","journal-title":"Am J Hematol"},{"key":"BFbmt2008401_CR11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/sj.bmt.1705660","volume":"39","author":"Y Khaled","year":"2007","unstructured":"Khaled Y, Kato K, Janakiraman N, Ferrara JL, Mineishi S . Early relapses do not impact survival after autologous stem cell transplantation in African Americans with multiple myeloma. Bone Marrow Transplant 2007; 39: 727\u2013728.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008401_CR12","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blad\u00e9","year":"1998","unstructured":"Blad\u00e9 J, Samson D, Reece D, Apperley J, Bj\u00f6rkstrand B, Gahrton G et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 1998; 102: 1115\u20131123.","journal-title":"Br J Haematol"},{"key":"BFbmt2008401_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.bmt.1703818","volume":"31","author":"E Terpos","year":"2003","unstructured":"Terpos E, Apperley JF, Samson D, Giles C, Crawley C, Kanfer E et al. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Bone Marrow Transplant 2003; 31: 163\u2013170.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008401_CR14","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.bmt.1705307","volume":"37","author":"D O'Shea","year":"2006","unstructured":"O'Shea D, Giles C, Terpos E, Perz J, Politou M, Sana V et al. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients. Bone Marrow Transplant 2006; 37: 731\u2013737.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008401_CR15","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1182\/blood-2002-03-0889","volume":"101","author":"CM Segeren","year":"2003","unstructured":"Segeren CM, Sonneveld P, van der Holt B, Vellenga E, Croockewit AJ, Verhoef GEG et al. Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 study. Blood 2003; 101: 2144\u20132151.","journal-title":"Blood"},{"key":"BFbmt2008401_CR16","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/blood-2004-02-0408","volume":"104","author":"A Palumbo","year":"2004","unstructured":"Palumbo A, Bringhen S, Petrucci MT, Musto P, Rossini F, Nunzi M et al. Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. Blood 2004; 104: 3052\u20133057.","journal-title":"Blood"},{"key":"BFbmt2008401_CR17","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1182\/blood-2005-03-1301","volume":"106","author":"J Blad\u00e9","year":"2005","unstructured":"Blad\u00e9 J, Rosi\u00f1ol L, Sureda A, Ribera JM, D\u00edaz-Mediavilla J, Garc\u00eda-Lara\u00f1a J et al. High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA. Blood 2005; 106: 3755\u20133759.","journal-title":"Blood"},{"key":"BFbmt2008401_CR18","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1046\/j.1365-2141.2000.02012.x","volume":"109","author":"JJ Lahuerta","year":"2000","unstructured":"Lahuerta JJ, Martinez-Lopez J, Serna JD, Blad\u00e9 J, Grande C, Alegre A et al. Remission status defined by immunofixation vs electrophoresis after autologous transplantation has a major impact on the outcome of multiple myeloma patients. Br J Haematol 2000; 109: 438\u2013446.","journal-title":"Br J Haematol"},{"key":"BFbmt2008401_CR19","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/sj.bmt.1703035","volume":"27","author":"R Alexanian","year":"2001","unstructured":"Alexanian R, Weber D, Giralt S, Dimopoulos M, Delasalle K, Smith T et al. Impact of complete remission with intensive therapy in patients with responsive multiple myeloma. Bone Marrow Transplant 2001; 27: 1037\u20131043.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008401_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/sj.bmt.1704313","volume":"33","author":"E Nadal","year":"2004","unstructured":"Nadal E, Gin\u00e9 E, Blad\u00e9 J, Esteve J, Rosi\u00f1ol L, Fern\u00e1ndez-Avil\u00e9s FF et al. High-dose therapy\/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission. Bone Marrow Transplant 2004; 33: 61\u201364.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008401_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/sj.bmt.1704728","volume":"35","author":"M Krejci","year":"2005","unstructured":"Krejci M, Buchler T, Hajek R, Svobodnik A, Krivanova A, Pour L et al. Prognostic factors for survival after autologous transplantation: a single centre experience in 133 multiple myeloma patients. Bone Marrow Transplant 2005; 35: 159\u2013164.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008401_CR22","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1002\/cncr.21804","volume":"106","author":"RA Kyle","year":"2006","unstructured":"Kyle RA, Leong T, Li S, Oken MM, Kay NE, Van Ness B et al. Complete response in multiple myeloma: clinical trial E9486, an Eastern Cooperative Oncology Group study not involving stem cell transplantation. Cancer 2006; 106: 1958\u20131966.","journal-title":"Cancer"},{"key":"BFbmt2008401_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.bmt.1704562","volume":"34","author":"R Alexanian","year":"2004","unstructured":"Alexanian R, Weber D, Delasalle K, Handy B, Champlin R, Giralt S . Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma. Bone Marrow Transplant 2004; 34: 229\u2013234.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008401_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/sj.bmt.1704545","volume":"34","author":"S Kumar","year":"2004","unstructured":"Kumar S, Lacy MQ, Dispenzieri A, Rajkumar SV, Fonseca R, Geyer S et al. High-dose therapy and autologous stem cell transplantation for multiple myeloma poorly responsive to initial therapy. Bone Marrow Transplant 2004; 34: 161\u2013167.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008401_CR25","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","volume":"64","author":"R Fonseca","year":"2004","unstructured":"Fonseca R, Barlogie B, Bataille R, Bastard C, Bergsagel PL, Chesi M et al. Genetics and cytogenetics of multiple myeloma: a workshop report. Cancer Res 2004; 64: 1546\u20131558.","journal-title":"Cancer Res"},{"key":"BFbmt2008401_CR26","doi-asserted-by":"publisher","first-page":"6339","DOI":"10.1200\/JCO.2005.05.023","volume":"23","author":"AK Stewart","year":"2005","unstructured":"Stewart AK, Fonseca RR . Prognostic and therapeutic significance of myeloma genetics and gene expression profiling. J Clin Oncol 2005; 23: 6339\u20136344.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008401_CR27","first-page":"65","volume":"79","author":"BL Rapoport","year":"1991","unstructured":"Rapoport BL, Falkson HC, Falkson G . Prognostic factors affecting the survival of patients with multiple myeloma. A retrospective analysis of 86 patients. S Afr Med J 1991; 79: 65\u201367.","journal-title":"S Afr Med J"},{"key":"BFbmt2008401_CR28","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1200\/JCO.2006.08.5803","volume":"25","author":"R Walker","year":"2007","unstructured":"Walker R, Barlogie B, Haessler J, Tricot GG, Anaissie EE, Shaughnessy JDJD et al. Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol 2007; 25: 1121\u20131128.","journal-title":"J Clin Oncol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008401","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008401.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:06:41Z","timestamp":1648033601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,12]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["BFbmt2008401"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.401","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,12]]},"assertion":[{"value":"31 July 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}